Contact

Paxman publishes newsletter on new distribution partners in Indonesia and Bangladesh

Today, Paxman publishes the June issue of its newsletter aimed at shareholders, investors and other interested parties.

This month’s issue highlights that Paxman has signed distribution agreements with PT. Gekha Karunia Abad for Indonesia and VisionTech International for Bangladesh. With the agreement for Singapore, Paxman will establish its business in the world’s fourth most populous country. Singapore has a population of 270 million people, a well-established public health insurance system covering 80 percent of the country’s population, and an ambitious National Cancer Control Program to facilitate early detection and treatment of cancer. Bangladesh is one of the most densely populated countries in the world, with a population of over 164 million.

The newsletter also includes information on recruitments to Paxman’s quality team in the UK and international positions in France, Germany, India and Scandinavia, and that this month’s orders and installations include 5 systems to Southend Hospital in the UK, 4 to the Netherlands and 3 to Brazil, as well as orders to cancer centers in New Hampshire, Florida, Minnesota, Texas and Tennessee in the United States.

To read the newsletter and subscribe for upcoming issues, follow this link:

http://bit.ly/paxjun21en

PAXMAN’s investor newsletter is published monthly as a part of the company’s effort to strengthen its market communication together with the IR communication agency Honeybadger. Every published issue of the newsletter is available on PAXMANs website for investors, www.paxman.se. The company encourages feedback and requests on topics for upcoming issues of the newsletter.

What we do
Paxman are world leaders in chemotherapy side effect management on an ambitious journey to change the face of cancer through cryotherapy-based treatments. The Paxman mission is to democratise access to scalp cooling globally.
Learn more →
Financial Information
Read the latest Paxman financial reports. In these comprehensive documents, you will find a detailed overview of our financial performance, key milestones, and a strategic outlook for the future. Reports are published quarterly and annually.
Read reports  →
Investing in Paxman
Paxman has treated 100,000+ patients and installed 5,000+ systems in more than 65 countries worldwide. We are helping to manage the trauma of chemotherapy hair loss. By investing in Paxman, you're not just supporting a company; you're joining us in changing the face of cancer.
Visit the Investor Centre →
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram